Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.

Expert review of anti-infective therapy

Volumn 11, Issue 9, 2013, Pages 931-941

  Seyedmousavi, Seyedmojtaba ^a   Mouton, Johan W ^b   Verweij, Paul E ^b   Brüggemann, Roger J M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; POSACONAZOLE; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ASPERGILLOSIS; ASPERGILLUS; BLOOD; CLINICAL TRIAL (TOPIC); DOSE CALCULATION; DRUG ADMINISTRATION; DRUG EFFECTS; DRUG MONITORING; HUMAN; MICROBIOLOGY; PHYSIOLOGY;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; DRUG RESISTANCE, FUNGAL; HUMANS; PYRIMIDINES; TRIAZOLES; VORICONAZOLE;

EID: 84892534686     PISSN: None     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2013.826989     Document Type: Review

References (0)